PubRank

H L Fehm

Author PubWeight™ 130.00‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effects of sleep and circadian rhythm on human circulating immune cells. J Immunol 1997 2.08
2 The selfish brain: competition for energy resources. Neurosci Biobehav Rev 2004 1.87
3 Acute effects of recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy men. J Clin Endocrinol Metab 1998 1.70
4 Basal secretory activity of the hypothalamo-pituitary-adrenocortical axis is enhanced in healthy elderly. An assessment during undisturbed night-time sleep. Eur J Endocrinol 1994 1.52
5 Sleep disruption alters nocturnal ACTH and cortisol secretory patterns. Biol Psychiatry 1991 1.51
6 Binding of human, porcine and bovine insulin to insulin receptors from human brain, muscle and adipocytes and to expressed recombinant alternatively spliced insulin receptor isoforms. Diabetologia 1995 1.40
7 Improving influence of insulin on cognitive functions in humans. Neuroendocrinology 2001 1.22
8 Postmenopausal estrogen administration suppresses muscle sympathetic nerve activity. J Clin Endocrinol Metab 2001 1.16
9 Causes of obesity: looking beyond the hypothalamus. Prog Neurobiol 2007 1.15
10 Chronic fentanyl application induces adrenocortical insufficiency. J Intern Med 2005 1.13
11 Plasma epinephrine and norepinephrine concentrations of healthy humans associated with nighttime sleep and morning arousal. Hypertension 1997 1.11
12 Low cerebrospinal fluid insulin levels in obese humans. Diabetologia 2006 1.08
13 Sympathetic control of white adipose tissue in lean and obese humans. Acta Physiol Scand 2003 1.08
14 Central nervous system effects of intranasally administered insulin during euglycemia in men. Diabetes 1999 1.04
15 Glucose metabolism rather than insulin is a main determinant of leptin secretion in humans. J Clin Endocrinol Metab 2000 1.03
16 Different regulation of adrenocorticotropin and cortisol secretion in young, mentally healthy elderly and patients with senile dementia of Alzheimer's type. J Clin Endocrinol Metab 1991 1.03
17 The neuroendocrine control of glucose allocation. Exp Clin Endocrinol Diabetes 2002 1.02
18 Cytokine production and lymphocyte subpopulations in aged humans. An assessment during nocturnal sleep. Mech Ageing Dev 1995 1.02
19 EEG complexity and performance measures of creative thinking. Psychophysiology 1999 0.97
20 Sleep loss and the development of diabetes: a review of current evidence. Exp Clin Endocrinol Diabetes 2005 0.96
21 Nocturnal adrenocorticotropin and cortisol secretion depends on sleep duration and decreases in association with spontaneous awakening in the morning. J Clin Endocrinol Metab 1992 0.96
22 Effects of age and gender on pituitary-adrenocortical responsiveness in humans. Eur J Endocrinol 1995 0.96
23 Timing the end of nocturnal sleep. Nature 1999 0.96
24 Enhanced dynamic complexity in the human EEG during creative thinking. Neurosci Lett 1996 0.95
25 Effects of sleep on the production of cytokines in humans. Psychosom Med 1995 0.95
26 Differential and integral corticosteroid feedback effects on ACTH secretion in hypoadrenocorticism. J Clin Invest 1979 0.95
27 The significance of sleep onset and slow wave sleep for nocturnal release of growth hormone (GH) and cortisol. Psychoneuroendocrinology 1988 0.93
28 Night-time plasma cortisol secretion is associated with specific sleep stages. Biol Psychiatry 1986 0.93
29 Adaptation of cognitive function to hypoglycemia in healthy men. Diabetes Care 2000 0.93
30 Selective influence of the menstrual cycle on perception of stimuli with reproductive significance: an event-related potential study. Psychophysiology 2000 0.92
31 Paradoxical ACTH response to glucocorticoids in Cushing's disease. N Engl J Med 1977 0.92
32 The principle of homeostasis in the hypothalamus-pituitary-adrenal system: new insight from positive feedback. Am J Physiol Regul Integr Comp Physiol 2007 0.92
33 Systemic immune changes following meal intake in humans. Am J Physiol 1997 0.92
34 Serum adiponectin concentrations during a 72-hour fast in over- and normal-weight humans. Int J Obes (Lond) 2005 0.91
35 Differential effects of human and pork insulin-induced hypoglycemia on neuronal functions in humans. Diabetes 1990 0.91
36 A regulatory role of prolactin, growth hormone, and corticosteroids for human T-cell production of cytokines. Brain Behav Immun 2004 0.91
37 Excess triiodothyronine as a risk factor of coronary events. Arch Intern Med 2000 0.90
38 Hypothalamus-pituitary-adrenal activity during human sleep: a coordinating role for the limbic hippocampal system. Exp Clin Endocrinol Diabetes 1998 0.90
39 Supraphysiological hyperinsulinemia acutely increases hypothalamic-pituitary-adrenal secretory activity in humans. J Clin Endocrinol Metab 1999 0.89
40 Slow wave sleep drives inhibition of pituitary-adrenal secretion in humans. J Neuroendocrinol 1997 0.88
41 Losartan attenuates symptomatic and hormonal responses to hypoglycemia in humans. Clin Pharmacol Ther 2001 0.87
42 Interleukin-6 stimulates the hypothalamus-pituitary-adrenocortical axis in man. J Clin Endocrinol Metab 1994 0.87
43 Hormonal secretion during nighttime sleep indicating stress of daytime exercise. J Appl Physiol (1985) 1995 0.87
44 Somatostatin: a potent inhibitor of ACTH-hypersecretion in adrenal insufficiency. Klin Wochenschr 1976 0.87
45 Fetal hemoglobin in starvation ketosis of young women. Blood 1998 0.85
46 Brain potential changes after intranasal vs. intravenous administration of vasopressin: evidence for a direct nose-brain pathway for peptide effects in humans. Biol Psychiatry 1996 0.85
47 Gluco- and antimineralocorticoid effects on human sleep: a role of central corticosteroid receptors. Am J Physiol 1991 0.85
48 Corticotropin-releasing hormone-induced adrenocorticotropin and cortisol secretion depends on sleep and wakefulness. J Clin Endocrinol Metab 1993 0.84
49 Multiple cellular forms of corticotrophs in surgically removed pituitary adenomas and periadenomatous tissue in Cushing's disease. Am J Pathol 1982 0.84
50 The subcutaneous lipolytic response to regional neural stimulation is reduced in obese women. Diabetes 2000 0.84
51 Changes in cortisol and growth hormone secretion during nocturnal sleep in the course of aging. J Gerontol A Biol Sci Med Sci 1996 0.84
52 Hypoglycemia, but not insulin, acutely decreases LH and T secretion in men. J Clin Endocrinol Metab 2001 0.84
53 Influences of corticotropin-releasing hormone, adrenocorticotropin, and cortisol on sleep in normal man. J Clin Endocrinol Metab 1989 0.83
54 Influences of corticosteroids, dexamethasone and hydrocortisone on sleep in humans. Neuropsychobiology 1986 0.83
55 The effect of experimentally induced insulin resistance on the leptin response to hyperinsulinaemia. Int J Obes Relat Metab Disord 2002 0.83
56 Cyclic Cushing's syndrome combined with cortisol suppressible, dexamethasone non-suppressible ACTH secretion: a new variant of Cushing's syndrome. Acta Endocrinol (Copenh) 1985 0.83
57 Neuropsychological effects of vasopressin in healthy humans. Prog Brain Res 1998 0.83
58 Interferon-alpha acutely impairs sleep in healthy humans. Cytokine 2000 0.83
59 Hyperinsulinemia causes activation of the hypothalamus-pituitary-adrenal axis in humans. Int J Obes Relat Metab Disord 2001 0.83
60 Effects of neurotransmitters on the release of corticotropin releasing hormone (CRH) by rat hypothalamic tissue in vitro. Exp Brain Res 1980 0.83
61 Intraneural stimulation elicits an increase in subcutaneous interstitial glycerol levels in humans. J Physiol 1999 0.82
62 Relationship between metabolic parameters, blood pressure, and sympathoendocrine function in healthy young adults with low birth weight. Exp Clin Endocrinol Diabetes 2005 0.81
63 Scalp recorded direct current brain potentials during human sleep. Eur J Neurosci 1998 0.81
64 Entrainment of ultradian oscillations in the secretion of insulin and glucagon to the nonrapid eye movement/rapid eye movement sleep rhythm in humans. J Clin Endocrinol Metab 1996 0.81
65 Problems and artefacts in ACTH assay. Horm Metab Res 1972 0.81
66 Acute effects of aldosterone on the autonomic nervous system and the baroreflex function in healthy humans. J Neuroendocrinol 2006 0.81
67 Differential adaptation of neurocognitive brain functions to recurrent hypoglycemia in healthy men. Psychoneuroendocrinology 2005 0.81
68 Evidence for ACTH-unrelated mechanisms in the regulation of cortisol secretion in man. Klin Wochenschr 1984 0.81
69 Glucocorticoid influences on the auditory brain-stem responses in man. Electroencephalogr Clin Neurophysiol 1989 0.81
70 Spontaneous and stimulated secretion of QUSO-extractable immunoassayable ACTH in man. Klin Wochenschr 1974 0.81
71 Auditory reflex thresholds elevated by stress-induced cortisol secretion. Psychoneuroendocrinology 1993 0.80
72 Event-related brain potentials and working memory function in healthy humans after single-dose and prolonged intranasal administration of adrenocorticotropin 4-10 and desacetyl-alpha-melanocyte stimulating hormone. J Clin Psychopharmacol 2000 0.80
73 Vasopressin and oxytocin do not influence early sensory processing but affect mood and activation in man. Peptides 1992 0.80
74 Human memory and neurohypophyseal hormones: opposite effects of vasopressin and oxytocin. Psychoneuroendocrinology 1984 0.80
75 Greater efficacy of episodic than continuous growth hormone-releasing hormone (GHRH) administration in promoting slow-wave sleep (SWS). J Clin Endocrinol Metab 1996 0.80
76 Vasopressin but not oxytocin enhances cortical arousal: an integrative hypothesis on behavioral effects of neurohypophyseal hormones. Psychopharmacology (Berl) 1988 0.80
77 The meal-related peak in plasma cortisol is not mediated by radioimmunoassayable ACTH. Clin Physiol Biochem 1983 0.80
78 A single administration of dehydroepiandrosterone does not enhance memory performance in young healthy adults, but immediately reduces cortisol levels. Biol Psychiatry 1997 0.79
79 Accelerated ST-segment reduction after thrombolytic therapy with recombinant tissue plasminogen activator (rtPA) compared to urokinase. Jpn Heart J 1996 0.79
80 Dehydroepiandrosterone sulphate in Alzheimer disease. Lancet 1990 0.79
81 Acute suppression of muscle sympathetic nerve activity by hydrocortisone in humans. Hypertension 2000 0.79
82 Relationships between sleep stages and plasma cortisol: a single case study. Acta Endocrinol (Copenh) 1986 0.79
83 Influences of partial REM sleep deprivation and awakenings on nocturnal cortisol release. Biol Psychiatry 1988 0.79
84 Vasopressin regulates human sleep by reducing rapid-eye-movement sleep. Am J Physiol 1992 0.79
85 The stress hormone adrenocorticotropin enhances sympathetic outflow to the muscle vascular bed in humans. J Hypertens 1998 0.79
86 Changes in direct current (DC) potentials and infra-slow EEG oscillations at the onset of the luteinizing hormone (LH) pulse. Eur J Neurosci 2000 0.79
87 Influences of peripheral adrenocorticotropin 1-39 (ACTH) and human corticotropin releasing hormone (h-CRH) on human auditory evoked potentials (AEP). Psychopharmacology (Berl) 1990 0.78
88 Systemic growth hormone does not affect human sleep. J Clin Endocrinol Metab 1993 0.78
89 Increase in systolic blood pressure and catecholamine level during hyperinsulinemia in a placebo-controlled euglycemic clamp in healthy subjects. Exp Clin Endocrinol Diabetes 2000 0.78
90 Effects of diurnal sleep on secretion of cortisol, luteinizing hormone, and growth hormone in man. J Clin Endocrinol Metab 1994 0.78
91 Antecedent hypoglycaemia attenuates vascular endothelial growth factor response to subsequent hypoglycaemia in healthy men. Diabet Med 2005 0.78
92 No "ultra-short feedback mechanism" for ACTH. Neuroendocrinology 1974 0.78
93 Blocking of central nervous mineralocorticoid receptors counteracts inhibition of pituitary-adrenal activity in human sleep. J Clin Endocrinol Metab 1997 0.78
94 Taste thresholds in man are differentially influenced by hydrocortisone and dexamethasone. Psychoneuroendocrinology 1989 0.78
95 Pathophysiology of Cushing's disease. Pathobiol Annu 1979 0.78
96 Intranasal angiotensin II directly influences central nervous regulation of blood pressure. Am J Hypertens 1998 0.78
97 Fatigue and hyponatremia in a 75-year-old woman: unusual presentation of hypophysitis. Exp Clin Endocrinol Diabetes 2001 0.78
98 Preserved hypothermic response to hypoglycemia after antecedent hypoglycemia. Metabolism 2000 0.78
99 Enhanced selective attention after low-dose administration of the benzodiazepine antagonist flumazenil. J Clin Psychopharmacol 1998 0.78
100 High plasma VEGF relates to low carbohydrate intake in patients with type 2 diabetes. Int J Obes (Lond) 2006 0.78
101 Effects of cholecystokinin and calcitonin on evoked brain potentials and satiety in man. Physiol Behav 1989 0.78
102 Influences of cortisol on auditory evoked potentials (AEPs) and mood in humans. Neuropsychobiology 1989 0.77
103 Two ACTH species in rat pituitary gland. FEBS Lett 1973 0.77
104 Enhanced psychophysiological signs of attention after angiotensin-converting enzyme inhibition by captopril. Psychophysiology 1996 0.77
105 Simultaneous stimulation test for the anterior pituitary hormones. Horm Metab Res 1974 0.77
106 No expression of ir-ACTH on stimulated peripheral blood leukocytes. Horm Metab Res 1987 0.77
107 Differential effects of hydrocortisone, fluocortolone, and aldosterone on nocturnal sleep in humans. Acta Endocrinol (Copenh) 1987 0.77
108 Verbal memory after three months of intranasal vasopressin in healthy old humans. Psychoneuroendocrinology 1997 0.77
109 Nocturnal wakefulness inhibits growth hormone (GH)-releasing hormone-induced GH secretion. J Clin Endocrinol Metab 1995 0.77
110 Familial coexistence of primary antiphospholipid syndrome and factor VLeiden. Lupus 1998 0.77
111 [Glucocorticoid-induced diabetes mellitus in gastrointestinal diseases]. Z Gastroenterol 1999 0.77
112 Effects of menstrual cycle on creativity. Psychoneuroendocrinology 1994 0.77
113 Sleep and wakefulness affect the responsiveness of the pituitary-adrenocortical axis to arginine vasopressin in humans. Neuroendocrinology 1994 0.77
114 Hypophysis and function of pancreatic islets. I. The influence of hypophysectomy on insulin secretion and biosynthesis of proinsulin and insulin in isolated pancreatic islets of rats. Diabetologia 1973 0.77
115 Comparison of the inhibitory effect of insulin and hypoglycemia on insulin secretion in humans. Metabolism 2000 0.77
116 Vasopressin and electrophysiological signs of attention in man. Peptides 1986 0.77
117 Jealousy, general creativity, and coping with social frustration during the menstrual cycle. Arch Sex Behav 1996 0.77
118 A nose-brain pathway for psychotropic peptides: evidence from a brain evoked potential study with cholecystokinin. Psychoneuroendocrinology 1996 0.77
119 Brain potentials and attention after acute and subchronic intranasal administration ofACTH 4-10 and desacetyl-alpha-MSH in humans. Neuroendocrinology 1999 0.77
120 Effects of insulin and hypoglycemia on the auditory brain stem response in humans. J Neurophysiol 1994 0.77
121 Metformin does not adversely affect hormonal and symptomatic responses to recurrent hypoglycemia. J Clin Endocrinol Metab 2001 0.77
122 Sensory processing during early and late nocturnal sleep. Electroencephalogr Clin Neurophysiol 1996 0.77
123 Selective influence of menstrual cycle on perception of stimuli with reproductive significance. Psychosom Med 1995 0.77
124 A determinant factor in the efficacy of GHRH administration in promoting sleep: high peak concentration versus recurrent increasing slopes. Psychoneuroendocrinology 1999 0.77
125 Growth in monolayer culture of rat pituitary cells which synthetize and release acth. Acta Endocrinol (Copenh) 1975 0.77
126 Comparison of satiating effects of ceruletide and food intake using behavioral and electrophysiological indicators of memory. Int J Psychophysiol 1994 0.77
127 Slow potential shifts at sleep--wake transitions and shifts between NREM and REM sleep. Sleep 1996 0.77
128 The "midday surge" in plasma cortisol induced by mental stress. Horm Metab Res 1984 0.77
129 Improved event-related potential signs of selective attention after the administration of the cholecystokinin analog ceruletide in healthy persons. Biol Psychiatry 1995 0.77
130 Signs of sexual behaviour are not increased after subchronic treatment with LHRH in young men. Psychoneuroendocrinology 2001 0.76
131 Effects of vasopressin on event-related potential indicators of cognitive stimulus processing in young and old humans. J Gerontol 1994 0.76
132 Dose-dependent influences on electrophysiological signs of attention in humans after neuropeptide ACTH 4-10. Exp Brain Res 1987 0.76
133 ACTH and attention in humans: a review. Neuropsychobiology 1986 0.76
134 Effects of DGAVP on verbal memory. Peptides 1989 0.76
135 Time course of ACTH 4-10 effects on human attention. Neuroendocrinology 1990 0.76
136 Dishabituating effects of an ACTH 4-9 analog in a vigilance task. Pharmacol Biochem Behav 1984 0.76
137 Adrenocorticotropin widens the focus of attention in humans. A nonliner electroencephalographic analysis. Psychosom Med 1997 0.76
138 Vasopressin does not enhance memory processes: a study in human twins. Peptides 1985 0.76
139 Corticosteroid receptor mediated effects on mood in humans. Psychoneuroendocrinology 1996 0.76
140 Cortisol effects on attentional processes in man as indicated by event-related potentials. Psychophysiology 1987 0.76
141 An ACTH 4-9 analog impairs selective attention in man. Life Sci 1985 0.76
142 Rhythms of pituitary-adrenal activity during sleep in patients with Cushing's disease. Exp Clin Endocrinol Diabetes 2000 0.76
143 Antimineralocorticoid canrenoate enhances secretory activity of the hypothalamus-pituitary-adrenocortical (HPA) axis in humans. Neuroendocrinology 1993 0.76
144 Sleep and endocrine changes after intranasal administration of growth hormone-releasing hormone in young and aged humans. Psychoneuroendocrinology 1999 0.76
145 Drinking related direct current positive potential shift in the human EEG depends on thirst. Neurosci Lett 2001 0.76
146 Effects of calcitonin on human auditory and visual evoked brain potentials. Psychopharmacology (Berl) 1992 0.76
147 Psychoneuroendocrine disturbances in a patient with a rare granulomatous disease. Exp Clin Endocrinol Diabetes 2002 0.76
148 The effect of somatostatin and of prolyl-leucyl-glycinamide (MIF) on ACTH release in dispersed pituitary cells. Life Sci 1977 0.76
149 Regulation of human thought by neuropeptide ACTH 4-10: an analysis of the EEG's dimensional complexity. Neuroreport 1997 0.76
150 Acute effects of desipramine and clomipramine on pituitary-adrenal axis in man. Horm Metab Res 1986 0.75
151 Neurophysiological effects of recombinant interferon-gamma and -alpha in man. Clin Physiol Biochem 1989 0.75
152 Counter-regulatory hormone responses to human and porcine insulin induced hypoglycaemia. Lancet 1990 0.75
153 Evidence for central nervous effects of corticotropin-releasing hormone on gastric acid secretion in humans. Neuroendocrinology 1997 0.75
154 Positive rate-sensitive corticosteroid feedback mechanism of ACTH secretion in Cushing's disease. J Clin Invest 1979 0.75
155 Cholinergic potentiation of the meal-related rise in ACTH and cortisol concentrations in men. Exp Clin Endocrinol 1994 0.75
156 Effect of an ACTH 4-9 analog on human cortical evoked potentials in a two-stimulus reaction time paradigm. Psychoneuroendocrinology 1981 0.75
157 Influence of exogenous atrial natriuretic peptide on the pituitary-adrenal response to corticotropin-releasing hormone and vasopressin in healthy men. J Clin Endocrinol Metab 1998 0.75
158 Different effects of human and porcine insulin on hypoglycemia-induced abnormalities of brainstem sensory function. Clin Physiol Biochem 1990 0.75
159 [Quality in hospital treatment. How is it assured and who determines the guidelines?]. Med Klin (Munich) 1997 0.75
160 Cholecystokinin-induced effects on selective attention depend on level of activation. Neuropsychobiology 1997 0.75
161 Studies on the pituitary "Fellstoffwechselhormon". V. The further purification of lipolytic active peptides from hog pituitary glands. Horm Metab Res 1974 0.75
162 Impact of sleep on the circadian excursions in the pituitary gonadotropin responsiveness of early follicular phase women. J Clin Endocrinol Metab 1993 0.75
163 Effects of an ACTH 4-9 analog on auditory evoked brainstem responses and middle latency responses. Pharmacol Biochem Behav 1985 0.75
164 Brain evoked responses, a bioassay for central actions of adrenocorticotropin (ACTH 1-39) and corticotropin releasing hormone (CRH) in humans. Horm Metab Res 1991 0.75
165 Influence of neuroactive drugs on corticosteroid feedback regulation of ACTH secretion in man. Horm Metab Res 1983 0.75
166 Effect of an ACTH 4-9 analog on human cortical evoked potentials in a constant foreperiod reaction time paradigm. Psychoneuroendocrinology 1981 0.75
167 [Criteria for surgical therapy of hypothalamo-hypophyseal Cushing's syndrome]. Chirurg 1977 0.75
168 Event-related brain potentials during identification of tachistoscopically presented pictures. Brain Cogn 1996 0.75
169 Dissociation of in vivo and in vitro "autonomy" in human adrenocortical tumour. Acta Endocrinol (Copenh) 1975 0.75
170 Sustained oscillatory insulin secretion after pancreas transplantation. Horm Metab Res 1990 0.75
171 [New aspects of physiology and of the clinical picture of ACTH secretion]. Med Klin 1979 0.75
172 [Importance of the central nervous system in the etiology of Cushing's syndrome]. Verh Dtsch Ges Inn Med 1980 0.75
173 Angiotensin converting enzyme inhibition by captopril influences cardiac work in healthy hearts. Am J Hypertens 1998 0.75
174 [Diagnosis and therapy of adrenal cortex insufficiency]. Dtsch Med Wochenschr 1990 0.75
175 Scalp recorded direct current potential shifts associated with the transition to sleep in man. Electroencephalogr Clin Neurophysiol 1994 0.75
176 Production of antibodies to ACTH for use in radioimmunoassay. Horm Metab Res 1971 0.75
177 Differential regulation of human blood glucose level by interleukin-2 and -6. Exp Clin Endocrinol Diabetes 2005 0.75
178 Blood levels of TSH, HGH, cortisol and ACTH after synthetic thyrotropin releasing factor (TRF). Horm Metab Res 1971 0.75
179 Adrenal insufficiency secondary to hypothalamic corticotropin releasing factor (CRF) insufficiency with hyperpigmentation: a case report. Horm Metab Res 1976 0.75
180 [Effect of corticosteroid-containing antirheumatic combination drugs on endogenous ACTH and cortisol production. Long-term studies with a dexamethasone-containing drug in 10 healthy controls]. Fortschr Med 1979 0.75
181 Suppression of ACTH secretion by synthetic MSH-release inhibiting factor Pro-Leu-Gly-NH2 in Addison's disease. Horm Metab Res 1977 0.75
182 The effect of cyproterone acetate on adrenal cortical function in children with precocious puberty. Eur J Pediatr 1978 0.75
183 The angiotensin converting enzyme inhibitors fosinopril and enalapril differ in their central nervous effects in humans. J Hypertens 1996 0.75
184 [Endocrine disorders in diseases of the CNS]. Med Welt 1983 0.75
185 [Diagnosis of an Ullrich-Turner syndrome in pension evaluation]. Dtsch Med Wochenschr 1994 0.75
186 Effects of vasopressin on the habituation of the orienting reaction in men. Peptides 1992 0.75
187 [Fatal complication of intravenous administration of synthetic adrenocorticotrophin]. Dtsch Med Wochenschr 1982 0.75
188 The behaviorally active peptide ACTH 4-10: measurement in plasma and pharmacokinetics in man. Eur J Clin Pharmacol 1988 0.75
189 Regulation of gonadotrophin secretion by inhibin, testosterone and gonadotrophin-releasing hormone in pituitary cell cultures of male monkeys. J Endocrinol 1998 0.75
190 Insulin stimulation of human adipocytes activates the kinase of only a fraction of the insulin receptors. Am J Physiol 1997 0.75
191 PreproTRH(158-183) fails to affect pituitary-adrenal response to CRH/vasopressin in man: a pilot study. Neuropeptides 2007 0.75
192 [Blood glucose, ACTH, cortisol, T4, T3 and rT3 after cholecystectomy. Comparative studies of continuous peridural anesthesia and neuroleptanalgesia]. Reg Anaesth 1984 0.75
193 Changes in immune cell counts and interleukin (IL)-1beta production in humans after a somnogenically active growth hormone-releasing hormone (GHRH) administration. Brain Behav Immun 2001 0.75
194 [Inhibitory effect of steroids on the secretion of ACTH in the hypothalamo-hypophyseal Cushing syndrome following adrenalectomy]. Verh Dtsch Ges Inn Med 1976 0.75
195 Insulin activation of insulin receptor kinase in erythrocytes is not altered in non-insulin-dependent diabetes and not influenced by hyperglycemia. J Endocrinol 2000 0.75
196 [Functional diagnosis of the hypothalamo-hypophyseal-adrenal system using radioimmunologic ACTH determination]. Verh Dtsch Ges Inn Med 1972 0.75
197 Evidence for extrapituitary mechanisms mediating the morning peak of plasma cortisol in man. J Clin Endocrinol Metab 1984 0.75
198 Influence of plasma on ACTH stimulated corticosterone production of isolated adrenal cells. FEBS Lett 1973 0.75
199 Time course of intranasally administered cholecystokinin-8 on central nervous effects. Neuropsychobiology 2001 0.75
200 [Corticosteroid containing antirheumatic combination drugs in the treatment of rheumatic diseases. Effect and tolerance of a dexamethasone containing drug in a stable therapeutic 10 day plan]. Fortschr Med 1978 0.75
201 [Addison disease with neurologic salience: an adrenomyeloneuropathic variant of adrenoleukodystrophy in a young male]. Med Klin (Munich) 1988 0.75
202 Lipolytically active peptides from hog pituitary glands. Acta Endocrinol Suppl (Copenh) 1973 0.75
203 [Inhibition of ACTH hypersecretion in Addison's disease by serotonin-antagonistic agents]. Verh Dtsch Ges Inn Med 1978 0.75
204 Stimulation of the pituitary adrenocortical system in man by cerulein, a cholecystokinin-8-like peptide. Clin Physiol Biochem 1988 0.75
205 Fragments of ACTH affect electrophysiological signs of controlled stimulus processing in humans. Psychopharmacology (Berl) 1989 0.75
206 [The effect of "stress hormones" on emotional sensitivity]. Z Exp Angew Psychol 1992 0.75
207 [Adrenocortical insufficiency as a result of isolated corticotropin-releasing hormone (CRH) deficiency (author's transl)]. Dtsch Med Wochenschr 1973 0.75
208 Studies on the pituitary "Fettstoffwechselhormon". 3. The corticotropic activity of some lipolytic effective hog pituitary gland fractions in vivo. Horm Metab Res 1970 0.75
209 Elevated plasma cortisol levels during interferon-gamma treatment. Immunopharmacology 1989 0.75
210 Influences of ACTH 4-10 on event-related potentials reflecting attention in man. Physiol Behav 1987 0.75
211 [Therapy with glucocorticoids]. MMW Munch Med Wochenschr 1982 0.75
212 Localization of corticotropin-releasing activity in the rat hypothalamus. Neurosci Lett 1976 0.75
213 [New aspects of the clinical neuroendocrinology of ACTH secretion]. Fortschr Med 1980 0.75
214 Evidence for effects of insulin on sensory processing in humans. Diabetes 1994 0.75
215 Combined pituitary stimulation test: interactions of hypothalamic releasing hormones in man. J Endocrinol Invest 1988 0.75
216 [Studies on hyperemesis gravidarum (author's transl)]. Geburtshilfe Frauenheilkd 1978 0.75
217 Disturbed cortisol secretion in man: contrasting Cushing's disease and endogenous depression. Psychiatry Res 1985 0.75
218 [Production of potent antiserums agiinst ACTH and their application in radioimmunoassay]. Acta Endocrinol Suppl (Copenh) 1971 0.75
219 Prolonged infusions of Ile5-angiotensin-II in sodium replete and deplete man: effects on aldosterone, ACTH, cortisol, blood pressure, and electrolyte balance. J Clin Endocrinol Metab 1978 0.75
220 Protective effect of insulin against hypoglycemia-associated counterregulatory failure. J Clin Endocrinol Metab 1999 0.75
221 [Progress in endocrinology]. MMW Munch Med Wochenschr 1982 0.75
222 [Clinicopathologic conference. Cerebral organic psychosyndrome with focal findings in computerized tomography and endocrine disorders in a 52-year-old male]. Med Klin (Munich) 1987 0.75
223 Dose-dependent influences on ERP indicators of attention after neuropeptide ACTH 4-10. Electroencephalogr Clin Neurophysiol Suppl 1987 0.75
224 Ceruletide improves event-related potential indicators of cognitive processing in young but not in elderly humans. J Clin Psychopharmacol 1996 0.75
225 [ACTH Radioimmunoassay, its value in clinical use]. Med Welt 1976 0.75
226 [Clinical and experimental observations in Cushing's syndrome based on an autonomous adrenal cortex tumor]. Verh Dtsch Ges Inn Med 1974 0.75
227 [Clinical aspects of hypophyseal-hypothalamic diseases]. Verh Dtsch Ges Inn Med 1987 0.75
228 Simultaneous stimulation test for the anterior pituitary hormones. Horm Metab Res 1974 0.75
229 Melatonin does not inhibit hypothalamic-pituitary-adrenal activity in waking young men. J Neuroendocrinol 2005 0.75
230 Sleep and signs of attention during 3 months of intranasal vasopressin: a pilot study in two elderly subjects. Peptides 1996 0.75
231 Effects of the neuropeptide PLG (L-prolyl-leucyl-glycinamide) on writing pressure and speed in healthy subjects. Pharmacopsychiatry 1988 0.75
232 Measurement of biological activity in various growth hormone preparations using a modified tibia test. Acta Endocrinol (Copenh) 1972 0.75
233 Studies on the pituitary "Fettstoffwechselhormon". IV. Comparisons between the lipolytic activity of ACTH and some fractions of porcine pituitaries in vitro. Horm Metab Res 1971 0.75
234 Delta-sleep-inducing peptide does not affect CRH and meal-induced ACTH and cortisol secretion. Psychoneuroendocrinology 1995 0.75
235 [Global pituitary stimulation test with releasing hormones]. Dtsch Med Wochenschr 1985 0.75
236 Influences of the cholecystokinin analog ceruletide on human sleep and evoked potentials. Neuropsychobiology 1990 0.75
237 Effect of estrogen replacement therapy on sympathetic activity in postmenopausal women. Circulation 2001 0.75
238 Distractability under the influence of an ACTH 4-9 derivative. Int J Neurosci 1983 0.75
239 Combined corticotropin-releasing hormone-vasopressin test: a new test for the evaluation of the pituitary adrenal system. Horm Metab Res 1987 0.75
240 The influence of a vasopressin-analogue (DGAVP) on event-related potentials in a stimulus-mismatch paradigm. Biol Psychol 1989 0.75
241 [Thoracic epidural anesthesia with 0.75% bupivacaine has no effect on ACTH-stimulated cortisol secretion]. Reg Anaesth 1984 0.75
242 Behavioral effects of vasopressin. Neuropsychobiology 1984 0.75
243 [Criteria for the surgical treatment of hypothalamo-hypophyseal-dependent Cushing's syndrome]. Langenbecks Arch Chir 1976 0.75
244 [Chronobiologic phenomena in endocrinology]. Internist (Berl) 1991 0.75
245 [Circadian rhythms in endocrinology]. Internist (Berl) 2004 0.75
246 Event-related brain potential correlates of self-reported hunger and satiety. Psychophysiology 1993 0.75
247 Cortisol deficiency in metomidate anesthetized bacteremic pigs: results in circulatory failure--beneficial effect of cortisol substitution. Acta Anaesthesiol Scand 1989 0.75
248 Evidence for an "ACTH binding factor" in plasma. Horm Metab Res 1971 0.75